Halyard Health Inc(NYSE:HYH) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 3, 2016. Earnings per share were $0.45.
Halyard Health Inc (HYH) shares turned negative on Fridays trading session with the shares closing down -0.1 points or -0.28% at a volume of 3,54,195. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $36.36. The peak price level was also seen at $36.36 while the days lowest was $35.96. Finally the shares closed at $36.23. The 52-week high of the shares is $36.81 while the 52-week low is $22.76. According to the latest information available, the market cap of the company is $1,691 M.
Several Insider Transactions has been reported to the SEC. On Sep 8, 2015, Robert E Abernathy (CEO) purchased 10,000 shares at $31.06 per share price.Also, On Sep 2, 2015, Steven E Voskuil (CFO) purchased 1,000 shares at $30.00 per share price.
Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.